ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens

被引:187
作者
Kannan, TR [1 ]
Baseman, JB [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Microbiol & Immunol, San Antonio, TX 78229 USA
关键词
ADP ribosylation; community-acquired respiratory distress syndrome toxin vacuolization;
D O I
10.1073/pnas.0510644103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Unlike many bacterial pathogens, Mycoplasma pneumoniae is not known to produce classical toxins, and precisely how M. pneumoniae injures the respiratory epithelium has remained a mystery for > 50 years. Here, we report the identification of a virulence factor (IMPN372) possibly responsible for airway cellular damage and other sequelae associated with M. pneumoniae infections in humans. We show that M. pneumoniae MPN372 encodes a 68-kDa protein that possesses ADP-ribosyltransferase (ART) activity. Within its N terminus, MPN372 contains key amino acids associated with NAD binding and ADP-ribosylating activity, similar to pertussis toxin (PTX) S1 subunit (PTX-S1). Interestingly, MPN372 AIDP ribosylates both identical and distinct mammalian proteins when compared with PTX-S1. Remarkably, MPN372 elicits extensive vacuolization and ultimate cell death of mammalian cells, including distinct and progressive patterns of cytopathology in tracheal rings in organ culture that had been previously ascribed to infection with WT virulent M. pneumoniae. We observed dramatic seroconverSion to MPN372 in patients diagnosed with M. pneumoniae-associated pneumonia, indicating that this toxin is synthesized in vivo and possesses highly immunogenic epitopes.
引用
收藏
页码:6724 / 6729
页数:6
相关论文
共 40 条
[1]  
BALIS JU, 1985, LAB INVEST, V52, P657
[2]  
Baseman J B, 1993, Subcell Biochem, V20, P243
[3]   Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety [J].
Baseman, JB ;
Tully, JG .
EMERGING INFECTIOUS DISEASES, 1997, 3 (01) :21-32
[4]   MOLECULAR-BASIS FOR CYTADSORPTION OF MYCOPLASMA-PNEUMONIAE [J].
BASEMAN, JB ;
COLE, RM ;
KRAUSE, DC ;
LEITH, DK .
JOURNAL OF BACTERIOLOGY, 1982, 151 (03) :1514-1522
[5]   INTERPLAY BETWEEN MYCOPLASMAS AND HOST TARGET-CELLS [J].
BASEMAN, JB ;
LANGE, M ;
CRISCIMAGNA, NL ;
GIRON, JA ;
THOMAS, CA .
MICROBIAL PATHOGENESIS, 1995, 19 (02) :105-116
[6]   Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections [J].
Baseman, JB ;
Reddy, SP ;
Dallo, SF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :S137-S144
[7]   NAD BINDING-SITE OF DIPHTHERIA-TOXIN - IDENTIFICATION OF A RESIDUE WITHIN THE NICOTINAMIDE SUBSITE BY PHOTOCHEMICAL MODIFICATION WITH NAD [J].
CARROLL, SF ;
COLLIER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (11) :3307-3311
[8]  
CLYDE WA, 1979, MYCOPLASMAS, V2, P275
[9]   Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation [J].
Cognet, I ;
de Coignac, AB ;
Magistrelli, G ;
Jeannin, P ;
Aubry, JP ;
Maisnier-Patin, K ;
Caron, G ;
Chevalier, S ;
Humbert, F ;
Nguyen, T ;
Beck, A ;
Velin, D ;
Delneste, Y ;
Malissard, M ;
Gauchat, JF .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 272 (1-2) :199-210
[10]  
COLLIER AM, 1971, P SOC EXP BIOL MED, V136, P569, DOI 10.3181/00379727-136-35313